Investors

In 2025, the hair loss market is expected to top US$12 billion. More than ever, people are concerned about their looks, lifestyle and general health.

98%

Rogaine and versions of private label Minoxidil control 98% of the topical hair growth market in the U.S.

40 years

No new FDA-approved drug has been marketed in the last 40 years.

$2 560

Average spent for hair loss products in the US per patient, per year.

Our
milestones

Looking to invest?

    Recent publications
    CORPORATE NEWS
    READ MORE
    Triple Hair
    Corporate
    Triple Hair Group announces the launch of Plenty Natural™
    READ MORE
    Triple Hair
    Corporate
    Triple Hair Group announces the launch of RIZN™
    READ MORE
    Triple Hair
    Corporate
    Triple Hair Group adds further expertise to board